Literature DB >> 27322717

Neoadjuvant Treatment With Cyclooxygenase-2 Inhibitor and Prednisolone Allows Conservative Surgery for Inflammatory Myofibroblastic Tumor of the Bladder.

Yusuke Tsuma1, Mitsuru Miyachi, Kazutaka Ouchi, Kunihiko Tsuchiya, Tomoko Iehara, Yasuyuki Naitoh, Eiichi Konishi, Akio Yanagisawa, Hajime Hosoi.   

Abstract

Inflammatory myofibroblastic tumor (IMT), which expresses cyclooxygenase-2 (COX-2), can be effectively treated with COX-2 inhibitor. Here, we report a case of urinary bladder IMT in a 13-year-old boy. Although total cystectomy was initially planned for complete resection of the tumor, neoadjuvant treatment with COX-2 inhibitor and prednisolone reduced the size of the tumor and enabled complete resection of the tumor by partial cystectomy. Neoadjuvant treatment with COX-2 inhibitor and prednisolone for IMT of the bladder allowed a more conservative surgical procedure that preserved bladder function.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27322717     DOI: 10.1097/MPH.0000000000000604

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  1 in total

1.  Inflammatory Myofibroblastic Tumor of the Urinary Bladder: An 11-Year Retrospective Study From a Single Center.

Authors:  Can Chen; Mengjun Huang; Haiqing He; Shuiqing Wu; Mingke Liu; Jun He; Hongjing Zang; Ran Xu
Journal:  Front Med (Lausanne)       Date:  2022-03-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.